Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
about
Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.Targeting the PTPome in human disease.Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound.Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases.Suramin is an active site-directed, reversible, and tight-binding inhibitor of protein-tyrosine phosphatases.
P2860
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@ast
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@en
type
label
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@ast
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@en
prefLabel
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@ast
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@en
P2093
P2860
P356
P1476
Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines.
@en
P2093
P2860
P304
P356
10.1172/JCI116102
P407
P577
1992-12-01T00:00:00Z